Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hextar Healthcare BhdXKLS:7803 Earnings Yield (Joel Greenblatt) % is -50.51% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 1,629 Chemicals companies, Hextar Healthcare Bhd ranks worse than 98.96% on this metric.
Hextar Healthcare Bhd's Enterprise Value for the quarter that ended in Mar. 2026 was RM71.1 Mil.
Hextar Healthcare Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was RM-35.8 Mil. Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was -50.51%.
The historical rank and industry rank for Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
XKLS:7803'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -110.25 Med: 6.72 Max: 1352.2
Current: -82.64
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Hextar Healthcare Bhd was 1352.20%. The lowest was -110.25%. And the median was 6.72%.
XKLS:7803's Earnings Yield (Joel Greenblatt) % is ranked worse than 98.96% of 1629
companies
in the Chemicals industry
Industry Median: 3.73
vs XKLS:7803: -82.64
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Hextar Healthcare Bhd's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Hextar Healthcare Bhd (XKLS:7803) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Hextar Healthcare Bhd Earnings Yield (Joel Greenblatt) % Related Terms
Hextar Healthcare Bhd Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hextar Healthcare Bhd Earnings Yield (Joel Greenblatt) % Chart
For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hextar Healthcare Bhd Earnings Yield (Joel Greenblatt) % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) % falls into.
Hextar Healthcare Bhd Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Hextar Healthcare Bhds Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Hextar Healthcare Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-35.8 Mil.
What does a Earnings Yield (Joel Greenblatt) % of -50.51% mean?
Hextar Healthcare Bhd (XKLS:7803) has a Earnings Yield (Joel Greenblatt) % of -50.51% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Hextar Healthcare Bhd and its competitors. According to the industry distribution chart, Hextar Healthcare Bhd ranks #1612 out of 1629 companies in the Chemicals industry, placing it in the top 99%.
Is Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) % too high?
Hextar Healthcare Bhd's current Earnings Yield (Joel Greenblatt) % is -50.51%. Based on the distribution chart, Hextar Healthcare Bhd ranks #1612 out of 1629 companies in the Chemicals industry, which is in the bottom quartile relative to peers.
How does Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Hextar Healthcare Bhd ranks #1612 out of 1629 companies for Earnings Yield (Joel Greenblatt) %. This places Hextar Healthcare Bhd in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Chemicals company?
The median Earnings Yield (Joel Greenblatt) % among Chemicals companies is 3.73, based on 1,629 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Hextar Healthcare Bhd and its competitors. For the Chemicals industry, the median Earnings Yield (Joel Greenblatt) % is 3.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hextar Healthcare Bhd's current Earnings Yield (Joel Greenblatt) % is -50.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.15, compared to a current price of RM0.07 — trading 56.7% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is -50.51%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current Earnings Yield (Joel Greenblatt) % is -50.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7803 has been successfully added to your 
